| Upcoming Application Deadlines |
|
|
【CEO炉边谈话|05】驻波X Lightelligence AI 深度对话
【CEO炉边谈话】CEO Fireside Chat Series 是MIT CEO推出的常规系列活动之一。每一期我们都将邀请到优秀的早期创业者或投资人与大家进行小规模的深度闭门交流，围绕技术层面和宏观大势开展深入的讨论。欢迎关注！
CEO炉边谈话第五期– 驻波X Lightelligence AI 深度对话
CEO Fireside Chat Series 05 - Zhubo X Lightelligence AI deep chat
时间Time
Friday, Dec. 7th, 6pm - 8pm
地点Location
MIT Campus (Will be notified via email if selected)
语言Language
English
注册链接Register Link
（扫描下方二维码 Scan to register）
内容Content
MIT CEO 联合驻波将于12月7号晚间6-8点在MT 举办一次围绕人工智能的深度对话。此次我们有幸邀请到了明星初创公司Lightelligence 的两位联合创始人：沈亦晨博士以及孟怀宇博士。Lightelligence 是一家利用光子代替电子进行深度学习计算的芯片初创公司。此次对话将会围绕人工智能，分享AI 芯片创业的心得与收获，分析现状，探究未来。机会难得，名额有限（20人），欢迎大波士顿地区对人工智能，半导体芯片感兴趣的朋友们参加！
MIT CEO & Zhubo will together hold a closed-door fireside chat about AI on Friday, Dec. 7th, 6pm - 8pm. Two of the co-founders of the very well-known Boston local startup Lightelligence: Dr. Yichen Shen and Dr. Huaiyu Meng will be our guest speakers. At this event they will cover topics related with Artificial Intelligence, and the emerging domain of AI semiconductor & chips, and analyze the current situation and share their future perspectives. We sincerely welcome students, professionals, faculties and VCs who have strong interest and/or work in this domain to join us. Because space is limited (only 20 slots available), only individuals with relevant background will invited to attend.
Lightelligence
By processing information with light, our chips offer orders of magnitude improvement in terms of high speed, low latency, and low power consumption compared to traditional electronic architectures. Our photonic circuits will unleash the potential of artificial intelligence and other high-performance computing tools.
分享嘉宾Guest Speakers
Dr. Yichen Shen: Co-Founder, CEO
Yichen Shen is a co-founder and CEO of Lightelligence. He received his Ph.D. degree in Physics from MIT in 2016, where his research focused on nanophotonics and artificial intelligence. Through his Ph.D., Yichen has published more than 25 peer-reviewed journal papers and has filed 10 US patents, including first authored papers in Science,Nature Photonics, and ICML(the top machine learning conference). In 2017, Yichen received Forbes 30 under 30 Global and MIT Technology Review 35 Innovators under 35 (TR35) China.
Dr. Huaiyu Meng: Co-Founder, VP of Photonics
Huaiyu Meng is a co-founder and VP of Photonics at Lightelligence. He received his Ph.D. degree in Electric Engineering from MIT, where his research focused on integrated photonics in CMOS platform for telecom, datacom, and bio-sensing applications. Huaiyu got his Bachelor’s degree from Nanyang Technological University in Electric Engineering with first class honor.
【MIT-CHIEF 年度峰会】拔萃出群，革故鼎新
点击上方关注MIT-CHIEF微信公众平台
每一个人都是孤独的奔跑者
是这理性与感性交织的社会中独自闪耀的星星
我们遥遥相望，期待一次擦肩带来的火花
漫漫长夜里，历史星河中，
数百万个人匆匆走过，数千万个小时悄然流逝，
你是否困于现状与本心的矛盾，
是否踌躇于无法到达的终点？
MIT-CHIEF 2018年度峰会
MIT 10-250, 222 Memorial Dr.
Cambridge, MA
2018年11月17日-18日
点击文末“阅读原文”直达购票链接
Early Bird票量有限 报名从速
年会
部分嘉宾信息
George Church
哈佛医学院和MIT 教授、Wyss Institute创始人
美国科学院，美国工程院，美国艺术与科学学院三院院士，被誉为个人基因组学以及合成生物学的先锋，基因组编辑技术CRISPR-CAS9的先驱，2016年诺贝尔化学奖的热门候选人，并创立多家高科技公司如Editas, Egenesis，阿里巴巴达摩院十巨匠之一。
李丰
峰瑞资本创始合伙人
李丰，峰瑞资本创始合伙人，前 IDG 资本合伙人。过去 10 年，他主导投资了包括宜信（已上市）、Bilibili（已上市）、三只松鼠、英语流利说（已上市）、顺顺留学、清陶能源、club factory、洋葱数学、停简单、猪八戒、铜板街、挖财、河狸家、同盾科技、闪银、江小白、韩都衣舍、百分点、百融、Coinbase、Ripple Labs 等一系列优秀创业公司。他获评投中集团「2015年度中国最佳移动互联网产业投资人物TOP10」、华兴资本「2017年度最佳天使投资人」「2016年度影响力投资人」、新浪科技「2017中国顶级投资人排行榜Top50」、36氪「最具创业者欢迎的VC投资人」「新金融&新消费领域10大投资人」。
Harvey Lodish
麻省理工学院Whitehead教授
Harvey Lodish，麻省理工学院生物系与生物工程系教授。在红细胞发育，脂质代谢，长非编码RNA以及红细胞载体给药等多个领域都有重要贡献。Harvey是生物医学研究重镇怀特海德研究所创始人之一，身兼美国科学院院士，美国艺术与科学院院士，美国科学促进会会士。他本人主编教科书《Molecular Cell Biology》被称为细胞生物学“圣经”，实验室成员有两人获得诺贝尔奖。
Harvey是麻省生命科学中心科学顾问委员会founding chair，也是Genzyme，Arris Pharmaceuticals，Millennium Pharmaceuticals等生物科技巨头创始人。
胡哲人
流利说联合创始人
胡哲人，流利说联合创始人兼首席技术官。2012年9月，与中央【千人计划】专家、普林斯顿大学计算机博士、Google前产品经理王翌，以及Google前科学家林晖共同创立了英文流利说。胡哲人负责制定公司技术战略目标，带领业内资深团队开展技术研发工作，运用商业运营思维，深度参与公司商业战略讨论，确保公司技术及产品始终处于市场领先水平。
Gordon Freeman
哈佛医学院教授
哈佛医学院教授，癌症免疫治疗领域先驱。2014年，Gordon Freeman 曾同京都大学Tasuhu Honjo、哈佛大学Arlene Sharpe和陈列平教授共同获得过肿瘤免疫学领域顶级大奖——威廉·科利奖（William B.Coley Award）。2016年获得引文桂冠奖（Citation Laureates）。2018年Gordon Freeman与 James Allison，Leiping Chen, Tasuku Honjo 以及Arlene Sharpe共获Warren Alpert Foundation Prize，其中James Allison与Tasuku Honjo分享了2018年的诺贝尔生理医学奖，而业界认为其中应该包含Gordon Freeman与陈列平，而且更为有意思的是Gordon Freeman与Arlene Sharpe又是免疫治疗领域的金伉俪。
韩峰
Blockchain Pillar and Foundation创始人
韩锋，麻省理工学院Blockchain Pillar and Foundation创始人、清华大学iCenter导师、亚洲区块链DACA协会秘书长、亦来云基金会理事，主编了《区块链新经济蓝图及导读》，《区块链开发与实例》，《区块链—量子财富观》等专著，参与开发了清华大学研究生课程《赛博智能经济和区块链》并任主讲之一。
嘉宾信息持续更新中，敬请期待...
2018 MIT-CHIEF Annual Conference
六大主题
人工智能
健康医疗
区块链
风险投资
Rising startup
炉边谈话
2018 Annual Conference
我们回溯历史，从中寻找只属于你的那一瞬间
我们放眼未来，为你定制独一无二的那条轨迹
在这里，你是独立运转的星体，也是苍穹群星的一员
历史即是人生，错过的机遇千载难回
改变只需一瞬，也许你需要的只是一个时机
让我们成为你的灵感，成为这浩瀚宇宙中的一粒火光
让我们触发你的能量，在这一刻拥有撬动世界的力量
让我们的努力，成就你生命中群星闪耀的时刻。
售票链接：
https://www.eventbrite.com/e/2018-mit-chief-annual-conference-tickets-51995227124?aff=eac2
或点击文末“阅读原文”直达购票链接
更多信息及年会日程表
请查看www.mitchief.org
同时，2018MIT-CHIEF 商业计划书大赛
将在年会中进行最后的角逐
4万美金现金大奖
百支优秀团队逐鹿赛场
六大前沿方向精彩碰撞
11月17日下午4点最终决战
8支顶尖队伍巅峰对决
最具潜力的BP、最有活力的团队
最辛辣的评论、最激烈的交锋
新技术/新思维/新业态/新盈利点/新商业模式
我们等待你的到来！
MIT-CHIEF是附属于麻省理工学院的学生组织，自创立伊始，已成为美国东部华人第一大创业社区。通过创业年会、商业计划大赛、中国行、明珠计划等一系列品牌活动，为中美两地创业生态圈建立了一条“丝绸之路”。同时，MIT-CHIEF创业社区所提供的创业沙龙、前沿科技论坛、培训项目和导师项目等等陪伴着一代又一代的逐梦人一路同行与成长。
MIT-CHIEF 2018 Community向创业团队正式开放！
输入网址http://mitchief.org/startup-portal
入驻创业生态圈
更多详情 请咨询community @mitchief.org
Homepage
www.mitchief.org
Facebook
MIT-China Innovation and Entrepreneurship Forum
Twitter
@chiefmit
Weibo
@MIT中国创新与创业论坛
LinkedIn
MIT-China Innovation and Entrepreneurship Forum
点击“阅读原文”直达年会购票链接
I would like to invite you to apply for the Dongsheng-Dao Ventures North America-China Entrepreneurship Competition 2018 by simply going to the Dao Ventures website at www.daoventures.com/application and using a few minutes to complete a one-page Competition Application Form. Your entrepreneurial initiative is a venture that we are certainly interested in getting to know more about through this Competition.
Please be advised that the deadline date for application is now November 12 and final competition day for the upcoming Dongsheng-Dao Ventures North America-China Entrepreneurship Competition 2018 is currently scheduled for November 29, Thursday at the Arlington Economic Development office in the Greater Washington region. The exact location is 1100 N. Glebe Road, Suite 1500, Arlington, VA 22201.
Additionally, both the 1st and 2nd place winners of the North America competition will be invited to China to compete in the Global Final Competition in Beijing to be held mid-December (exact date TBD)
As such, the following updates are provided, as follows:
· Application deadline date: November 12, 2018
· Top applicants chosen and notified as North America competition finalists: November 16, 2018
· North America Cmpetition Day: November 29, 2018 in Arlington, Virginia
· Finalists who reside outside the Greater D.C., Virginia or Maryland metropolitan areas will be provided with up to $500 in travel stipend to attend the competition in Arlington, VA
Participants in the U.S. competition have the chance to win:
· $10,000 prize for 1st place (China airfare stipend included)
· $5,000 prize for 2nd place (China airfare stipend included)
· $1,000 prize for 3rd place
North America 1st and 2nd place winners:
· Will need to participate in the final global competition to be held in Beijing in mid-December (exact date TBD)
· Will need to obtain a Chinese Tourist visa from the Chinese Consulate as needed
· Will have a fully paid 5 nights stay at a luxury hotel in Beijing
· Will have the chance to potentially win the Grand Prize of approximately $150,000 or one of the lesser 'placement' prizes to be awarded in the global final competition in Beijing
· Will be provided with the opportunity to meet prospective Chinese investors and/or partners in Beijing
· Will have the opportunity to win free work space in the Dongsheng-Dao Ventures International Accelerator in Beijing
· Will have access to post-competition, China-focused consulting and mentoring services
If you may have any question about this Competition, please don't hesitate to let me know. Thank you for your interest.
Regards,
_______________________________________________ Mitceo-info mailing list Mitceo-info@mit.edu http://mailman.mit.edu/mailman/listinfo/mitceo-info
The inaugural CEO Fireside Chat Series:
Development and Challenges of Public Blockchains:
A Conversation with BUMO
Many flavors of blockchain have evolved over the years. Public blockchain, which has been one of the most popular types, has experienced both rapid development and significant challenges in the past few years. Bitcoin is one of the largest and most well-known public blockchain networks in production today.
One of the biggest challenges of a public blockchain is the substantial amount of computational power that is necessary to maintain a distributed ledger at a large scale. To achieve consensus, each node in a network must solve a complex, resource-intensive cryptographic problem called a proof of work to ensure all are in sync. Another disadvantage is the openness of public blockchain, which implies little to no privacy for transactions and only supports a weak notion of security. Due to these drawbacks, to date there are few instances of successful business application for most public chains, despite the widely held belief that the blockchain technology has the potential of fundamentally change almost every business sector.
In this event, we have invited a group of leading experts to share their opinion on pressing topics such as how the blockchain technology would evolve, technologies to improve public chain scalability & efficacy, and their thinking on the future of public chains.
【Time/时间】
October 29, 6 - 8pm
【Venue/地点】
MIT
(address with be informed via email once registration has been confirmed)
【Agenda/日程】
6 - 7pm
Demonstration of next-generation blockchain: case-study of BUMO
By: Kevin Liu, Dennis Zhang
7 - 8 pm
Panel Discussion: Key Factors Driving the Sustainability of Public Chains
Panelists: Will Knight, Waikit Lau, Jin Wang, Dennis Zhang
Moderator: Tong Shen
【Language/语言】
English
【Registration /注册链接】
（扫描下方二维码或点击左下角阅读原文打开）
Guests speakers
Jing Wang
Mr Wang is Technical Consultant of BUMO Foundation. As one of the trailblazers of blockchain in China, Mr. Wang is a senior expert of business-use blockchain and holds variously related patents. He explores powerful approaches of blockchain for commercial use and has more than ten years of system design experience in the Internet field, especially in aspects such as distributed systems, complex network control, and cybersecurity. He once worked with famous companies like Huawei. Bubi Technologies, the FinTech blockchain company he co-founded in China, presents blockchain solutions for banks, insurances, logistics, supply chain finance, digital assets, etc.
Kevin Liu
Mr. Liu is Director of BUMO Foundation, North America. He is leading the community and ecosystem building in North America(US and Canada) for BUMO Foundation. He is also in charge of the BUMO Global Ambassadors Project and Open Source Developers Community. He has over 5 years' experience in the international market and business development. A practitioner in Mobile Internet entrepreneurship with an APP of 160m install base, which empowered him with the valuable experience in investment banking, product management, and operation management. Mr. Liu holds the MBA degree from the University of Chinese Academy of Sciences.
Weikit Lau
Mr. Waikit Lau is a serial entrepreneur. With 17+ years of experience in Technology and Finance, across product, marketing, and sales functions, he has been on both VC and operations sides. He is an active investor in ICO and 20+ startups, and will be teaching an upcoming MIT class on cryptocurrency. Mr. Lau's past investments include BladeLogic, Endeca, WaveSmith, Netli, Berkeley Design Automation, among others. He is also running AIDL (Artificial Intelligence & Deep Learning), one of the largest and most active Artificial Intelligence and Deep Learning communities with 85,000+ members. Mr. Lau holds BS in Electrical Engineering, Finance & Computer Science from MIT and MBA from Harvard Business School.
Will Knight
Will Knight is MIT Technology Review’s Senior Editor for Artificial Intelligence. He covers the latest advances in AI and related fields, including machine learning, automated driving, and robotics. Will’s most recent cover story, The Dark Secret at the Heart of AI, examined the opaque nature of today's most cutting machine learning algorithms. He is currently researching a story about China's recent surge of activity in artificial intelligence. Will joined MIT Technology Review in 2008 from the UK science weekly New Scientist magazine. He is a frequent guest on TV and radio shows.
Dennis Zhang
Dennis is CEO and Co-Founder of VitaData, a decentralized health data kickstarter powered by blockchain. Dennis is also the architect of the token economics and held PhD in Economics from Boston University. He is an entrepreneur with 10 years of experience in data algorithm and analytics and also an expert in digital health, smart wear, blockchain and AI.
Tong Shen
Tong Shen is the Co-founder and CTO of Liaoyuan, a social networking platform for entrepreneurs, investors, and industry professionals to efficiently acquire valuable resources and connect with each other. Tong held Masters in Computer Science from Brandeis University. He is a serial entrepreneur with experience in social network, blockchain and app development.
Event Partner
BUMO is a new generation of commercial-grade basic public chain, and builds the Internet infrastructure for Ubiquitous Value Transfer through core technologies such as An Improved Two-layer Consensus Protocol (BU Firework), Two-layer Polymorphic Architecture for Multi-child Blockchain (BU Orbits), Inter-Chain for Routing Value across Blockchains (BU Canal), Developer-friendly Smart Contract on Blockchain (BU CodeMach), etc.
--
[About MIT CEO]
MIT CEO (MIT Chinese Entrepreneurs Organization) is a MIT-funded student group founded by a group of students and alumni from MIT, Harvard and other schools as well as young entrepreneurs and professionals around Boston area. Our mission is to help members to build world-class companies, to create a sustained collaboration mechanism between high-tech community and large Chinese corporations, as well as to help efficiently connect esteemed investors with high quality startups around Boston area. If you would like to hear about more MIT CEO events, please go to following page to subscribe to our mailing list mitceo-info@mit.edu: http://mailman.mit.edu/mailman/listinfo/mitceo-info. If you would like to contact MIT CEO, please e-mail to mitceo@mit.edu
【MIT CEO 创业讲堂】 第三期
< Flagship Pioneering > Case Study 案例讨论
With prof. Hong Luo of HBS
【Time/时间】
October 15, 6-8pm
6:00 - 6: 30 Reception with Light Dinner
6:30 - 8:00 Case Study
【Venue/地点】
MIT (Room number will be sent to your email address if invited)
【Language/语言】
English
【Co-host/协办】
PIP 破蛋计划
【Registration Link/注册链接】
A fee will be charged to participants to purchase the Case material from Harvard Business School. Due to limited capacity of the venue, your application will be reviewed by MIT CEO, and those who would benefit the most from this lecture will be invited to participate. If you are not invited, both ticket cost and fee will be fully refunded prior to the event.
本次活动将收费用于购买哈佛商学院案例。教材及活动地址将在报名入选后邮件发送。因名额有限，我们会对报名者职业背景进行筛选，挑选能够获益最多的学员参与。如您未被邀请参加，门票及手续费将在活动前全部退还。
The “Entrepreneuring” Vision
In 1987, Noubar Afeyan earned his Ph.D. in Biochemical Engineering from MIT and embarked upon the journey of entrepreneurship. Over the next decade, Dr. Afeyan contributed to the founding of six biotech companies, all of which went public or were acquired by the end of 1990s. As a serial entrepreneur, Noubar has the vision to transform the way startups are built: to systematically perpetuate entrepreneurship. Believing that Greater Boston has a strong ecosystem built of academic science, the hospitals, and the patient community, Dr. Afeyan founded Flagship in Cambridge.
Institutionalized Innovation
Since its inception in 2000, Flagship Pioneering has raised more than $2.32 billion in funds, launched more than 96 portfolio companies with an aggregated valuation of $20 billion, and managed funds proven to be top performers among all VCs of the same vintage. Compared to a number of medium and large biopharmaceutical companies, Flagship Pioneering exhibited four times productivity in patenting. Some of the successful companies include Moderna Therapeutics, Seres Therapeutics, Agios Pharmaceuticals, and Acceleron Pharma.
What is the business model of Flagship Pioneering that made “Institutionalized Entrepreneurship” possible?
What are the critical elements in Flagship’s strategy that create value?
As companies enter the growth phase, what are the challenges that Flagship face?
Hong Luo will present an overview of the important elements behind the success story of Flagship Pioneering, and her perspectives on how strategy contributed to the company.
About Professor Hong Luo
Hong Luo is the James Dinan and Elizabeth Miller Associate Professor at Harvard Business School, where she teaches strategy courses to MBA, Executive Education, and doctoral students. Her research focuses on the commercialization of innovative ideas and the strategy utilized by entrepreneurs. She lectures widely in the United States and internationally on topics including economics, entrepreneurship, and innovation. Prior to Harvard Business School, she taught at Sloan School of Management at MIT, and began her career at Boston Consulting Group. Dr. Luo received her Ph.D. in Economics from Stern School of Business, New York University, where she was a recipient of the Kauffman Dissertation Fellowship in Entrepreneurship Research. Prior to her doctorate, Dr. Luo received M.A. in Economics from Peking University and B.A. in Finance from Renmin University of China.
_______________________________________________ Mitceo-info mailing list Mitceo-
麻省理工华人创业峰会
MIT CEO SUMMIT
创业 / 科技 / 学术 / 青年 / 影响
MIT CEO SUMMIT由麻省理工学院华人创业者协会（MIT CEO）、清华企业家协会美东分会（TEEC）、以及中国高校创新创业教育联盟投融资委员会（IEEAC）主办，致力于培养创业思维，促进前沿科技发展，打造高质量的创业团队。
峰会将聚集学术、产业和资本等各方资源，努力将高校等研究机构的优秀科研成果转化为创业公司，并进一步助其发展为有巨大影响力的行业领军者。
峰会将于2018年9月16日在麻省理工学院举办，并由三个部分组成：
主题论坛
创业大赛
黑客马拉松比赛
主 题 论 坛
P A N E L
▽
创新 / 科技 / 深度 / 全面 / 专业
论坛将于9月16日上午9点至下午2点进行，以深度科技创新为主题，包括数场演讲和专题讨论，涵盖多个新兴、热门领域：
脑科学
区块链
人工智能
医疗健康
新材料／能源
创 业 大 赛
C O M P E T I T I O N
▽
创业基金 / 投资人 / 导师 / 媒体 / 推广
此次峰会特设创业大赛环节，将会有60余支团队参与。创业大赛将在主题论坛结束后进行，旨在全方位展现创业者的独特风采，帮助创业者与投资人进行有效对接，并对优秀团队提供资金奖励。
目前峰会仍接受参赛报名，剩余空位火速递减中，欢迎扫码报名，报名截止日期为9月9日。
20余家国内外知名基金参与：
泰有基金、真格基金、红杉资本、峰瑞资本、丹华资本、英诺天使基金、武岳峰资本、北大创投、水木清华校友基金、赛伯乐投资、由我、8D资本
创业大赛奖金设置：
一等奖1名：$20,000
二等奖2名：$10,000
优秀奖2名：$5,000
黑 客 马 拉 松
H A C K A T H O N
▽
全球化 / 新科技 / 区块链 / 打破壁垒
此次峰会还联合了全球Hacker组织，DoraHacks，将于9月22日开展一场持续24小时的以“新科技＋区块链”为主题的Hackathon黑客马拉松活动：
团队作战：
- 3-6人由底层开发、产品开发、产品设计等不同技能的参与者现场组成团队，一起战斗
限时极限挑战：
- 限时连续的讨论、设计出一款解决行业重要而迫切问题的产品
啤酒、脑洞、新科技：
- 这是一场有啤酒、思想、科技、脑洞的竞技狂欢，参与者可以在这里实现自己的创业，度过紧张、刺激、难忘的一天
峰会时间
2018年9月16日及9月22日
▽
峰会地点
MIT Building 34-101, 50 Vassar Street, Cambridge, MA 02139
▽
点击上方关注MIT-CHIEF微信公众平台
每一个人都是孤独的奔跑者
是这理性与感性交织的社会中独自闪耀的星星
我们遥遥相望，期待一次擦肩带来的火花
漫漫长夜里，历史星河中，
数百万个人匆匆走过，数千万个小时悄然流逝，
你是否困于现状与本心的矛盾，
是否踌躇于无法到达的终点？
MIT-CHIEF 2018年度峰会
MIT 10-250, 222 Memorial Dr.
Cambridge, MA
2018年11月17日-18日
点击文末“阅读原文”直达购票链接
Early Bird票量有限 报名从速
年会
部分嘉宾信息
George Church
哈佛医学院和MIT 教授、Wyss Institute创始人
美国科学院，美国工程院，美国艺术与科学学院三院院士，被誉为个人基因组学以及合成生物学的先锋，基因组编辑技术CRISPR-CAS9的先驱，2016年诺贝尔化学奖的热门候选人，并创立多家高科技公司如Editas, Egenesis，阿里巴巴达摩院十巨匠之一。
李丰
峰瑞资本创始合伙人
李丰，峰瑞资本创始合伙人，前 IDG 资本合伙人。过去 10 年，他主导投资了包括宜信（已上市）、Bilibili（已上市）、三只松鼠、英语流利说（已上市）、顺顺留学、清陶能源、club factory、洋葱数学、停简单、猪八戒、铜板街、挖财、河狸家、同盾科技、闪银、江小白、韩都衣舍、百分点、百融、Coinbase、Ripple Labs 等一系列优秀创业公司。他获评投中集团「2015年度中国最佳移动互联网产业投资人物TOP10」、华兴资本「2017年度最佳天使投资人」「2016年度影响力投资人」、新浪科技「2017中国顶级投资人排行榜Top50」、36氪「最具创业者欢迎的VC投资人」「新金融&新消费领域10大投资人」。
Harvey Lodish
麻省理工学院Whitehead教授
Harvey Lodish，麻省理工学院生物系与生物工程系教授。在红细胞发育，脂质代谢，长非编码RNA以及红细胞载体给药等多个领域都有重要贡献。Harvey是生物医学研究重镇怀特海德研究所创始人之一，身兼美国科学院院士，美国艺术与科学院院士，美国科学促进会会士。他本人主编教科书《Molecular Cell Biology》被称为细胞生物学“圣经”，实验室成员有两人获得诺贝尔奖。
Harvey是麻省生命科学中心科学顾问委员会founding chair，也是Genzyme，Arris Pharmaceuticals，Millennium Pharmaceuticals等生物科技巨头创始人。
胡哲人
流利说联合创始人
胡哲人，流利说联合创始人兼首席技术官。2012年9月，与中央【千人计划】专家、普林斯顿大学计算机博士、Google前产品经理王翌，以及Google前科学家林晖共同创立了英文流利说。胡哲人负责制定公司技术战略目标，带领业内资深团队开展技术研发工作，运用商业运营思维，深度参与公司商业战略讨论，确保公司技术及产品始终处于市场领先水平。
Gordon Freeman
哈佛医学院教授
哈佛医学院教授，癌症免疫治疗领域先驱。2014年，Gordon Freeman 曾同京都大学Tasuhu Honjo、哈佛大学Arlene Sharpe和陈列平教授共同获得过肿瘤免疫学领域顶级大奖——威廉·科利奖（William B.Coley Award）。2016年获得引文桂冠奖（Citation Laureates）。2018年Gordon Freeman与 James Allison，Leiping Chen, Tasuku Honjo 以及Arlene Sharpe共获Warren Alpert Foundation Prize，其中James Allison与Tasuku Honjo分享了2018年的诺贝尔生理医学奖，而业界认为其中应该包含Gordon Freeman与陈列平，而且更为有意思的是Gordon Freeman与Arlene Sharpe又是免疫治疗领域的金伉俪。
韩峰
Blockchain Pillar and Foundation创始人
韩锋，麻省理工学院Blockchain Pillar and Foundation创始人、清华大学iCenter导师、亚洲区块链DACA协会秘书长、亦来云基金会理事，主编了《区块链新经济蓝图及导读》，《区块链开发与实例》，《区块链—量子财富观》等专著，参与开发了清华大学研究生课程《赛博智能经济和区块链》并任主讲之一。
嘉宾信息持续更新中，敬请期待...
2018 MIT-CHIEF Annual Conference
六大主题
人工智能
健康医疗
区块链
风险投资
Rising startup
炉边谈话
2018 Annual Conference
我们回溯历史，从中寻找只属于你的那一瞬间
我们放眼未来，为你定制独一无二的那条轨迹
在这里，你是独立运转的星体，也是苍穹群星的一员
历史即是人生，错过的机遇千载难回
改变只需一瞬，也许你需要的只是一个时机
让我们成为你的灵感，成为这浩瀚宇宙中的一粒火光
让我们触发你的能量，在这一刻拥有撬动世界的力量
让我们的努力，成就你生命中群星闪耀的时刻。
售票链接：
https://www.eventbrite.com/e/2018-mit-chief-annual-conference-tickets-51995227124?aff=eac2
或点击文末“阅读原文”直达购票链接
更多信息及年会日程表
请查看www.mitchief.org
同时，2018MIT-CHIEF 商业计划书大赛
将在年会中进行最后的角逐
4万美金现金大奖
百支优秀团队逐鹿赛场
六大前沿方向精彩碰撞
11月17日下午4点最终决战
8支顶尖队伍巅峰对决
最具潜力的BP、最有活力的团队
最辛辣的评论、最激烈的交锋
新技术/新思维/新业态/新盈利点/新商业模式
我们等待你的到来！
MIT-CHIEF是附属于麻省理工学院的学生组织，自创立伊始，已成为美国东部华人第一大创业社区。通过创业年会、商业计划大赛、中国行、明珠计划等一系列品牌活动，为中美两地创业生态圈建立了一条“丝绸之路”。同时，MIT-CHIEF创业社区所提供的创业沙龙、前沿科技论坛、培训项目和导师项目等等陪伴着一代又一代的逐梦人一路同行与成长。
MIT-CHIEF 2018 Community向创业团队正式开放！
输入网址http://mitchief.org/startup-portal
入驻创业生态圈
入驻创业生态圈
更多详情 请咨询community @mitchief.org
Homepage
www.mitchief.org
Facebook
MIT-China Innovation and Entrepreneurship Forum
Twitter
@chiefmit
Weibo
@MIT中国创新与创业论坛
LinkedIn
MIT-China Innovation and Entrepreneurship Forum
点击“阅读原文”直达年会购票链接
I would like to invite you to apply for the Dongsheng-Dao Ventures North America-China Entrepreneurship Competition 2018 by simply going to the Dao Ventures website at www.daoventures.com/application and using a few minutes to complete a one-page Competition Application Form. Your entrepreneurial initiative is a venture that we are certainly interested in getting to know more about through this Competition.
Please be advised that the deadline date for application is now November 12 and final competition day for the upcoming Dongsheng-Dao Ventures North America-China Entrepreneurship Competition 2018 is currently scheduled for November 29, Thursday at the Arlington Economic Development office in the Greater Washington region. The exact location is 1100 N. Glebe Road, Suite 1500, Arlington, VA 22201.
Additionally, both the 1st and 2nd place winners of the North America competition will be invited to China to compete in the Global Final Competition in Beijing to be held mid-December (exact date TBD)
As such, the following updates are provided, as follows:
· Application deadline date: November 12, 2018
· Top applicants chosen and notified as North America competition finalists: November 16, 2018
· North America Cmpetition Day: November 29, 2018 in Arlington, Virginia
· Finalists who reside outside the Greater D.C., Virginia or Maryland metropolitan areas will be provided with up to $500 in travel stipend to attend the competition in Arlington, VA
Participants in the U.S. competition have the chance to win:
· $10,000 prize for 1st place (China airfare stipend included)
· $5,000 prize for 2nd place (China airfare stipend included)
· $1,000 prize for 3rd place
North America 1st and 2nd place winners:
· Will need to participate in the final global competition to be held in Beijing in mid-December (exact date TBD)
· Will need to obtain a Chinese Tourist visa from the Chinese Consulate as needed
· Will have a fully paid 5 nights stay at a luxury hotel in Beijing
· Will have the chance to potentially win the Grand Prize of approximately $150,000 or one of the lesser 'placement' prizes to be awarded in the global final competition in Beijing
· Will be provided with the opportunity to meet prospective Chinese investors and/or partners in Beijing
· Will have the opportunity to win free work space in the Dongsheng-Dao Ventures International Accelerator in Beijing
· Will have access to post-competition, China-focused consulting and mentoring services
If you may have any question about this Competition, please don't hesitate to let me know. Thank you for your interest.
Regards,
The inaugural CEO Fireside Chat Series:
Development and Challenges of Public Blockchains:
A Conversation with BUMO
Many flavors of blockchain have evolved over the years. Public blockchain, which has been one of the most popular types, has experienced both rapid development and significant challenges in the past few years. Bitcoin is one of the largest and most well-known public blockchain networks in production today.
One of the biggest challenges of a public blockchain is the substantial amount of computational power that is necessary to maintain a distributed ledger at a large scale. To achieve consensus, each node in a network must solve a complex, resource-intensive cryptographic problem called a proof of work to ensure all are in sync. Another disadvantage is the openness of public blockchain, which implies little to no privacy for transactions and only supports a weak notion of security. Due to these drawbacks, to date there are few instances of successful business application for most public chains, despite the widely held belief that the blockchain technology has the potential of fundamentally change almost every business sector.
In this event, we have invited a group of leading experts to share their opinion on pressing topics such as how the blockchain technology would evolve, technologies to improve public chain scalability & efficacy, and their thinking on the future of public chains.
【Time/时间】
October 29, 6 - 8pm
【Venue/地点】
MIT
(address with be informed via email once registration has been confirmed)
【Agenda/日程】
6 - 7pm
Demonstration of next-generation blockchain: case-study of BUMO
By: Kevin Liu, Dennis Zhang
7 - 8 pm
Panel Discussion: Key Factors Driving the Sustainability of Public Chains
Panelists: Will Knight, Waikit Lau, Jin Wang, Dennis Zhang
Moderator: Tong Shen
【Language/语言】
English
【Registration /注册链接】
（扫描下方二维码或点击左下角阅读原文打开）
Guests speakers
Jing Wang
Mr Wang is Technical Consultant of BUMO Foundation. As one of the trailblazers of blockchain in China, Mr. Wang is a senior expert of business-use blockchain and holds variously related patents. He explores powerful approaches of blockchain for commercial use and has more than ten years of system design experience in the Internet field, especially in aspects such as distributed systems, complex network control, and cybersecurity. He once worked with famous companies like Huawei. Bubi Technologies, the FinTech blockchain company he co-founded in China, presents blockchain solutions for banks, insurances, logistics, supply chain finance, digital assets, etc.
Kevin Liu
Mr. Liu is Director of BUMO Foundation, North America. He is leading the community and ecosystem building in North America(US and Canada) for BUMO Foundation. He is also in charge of the BUMO Global Ambassadors Project and Open Source Developers Community. He has over 5 years' experience in the international market and business development. A practitioner in Mobile Internet entrepreneurship with an APP of 160m install base, which empowered him with the valuable experience in investment banking, product management, and operation management. Mr. Liu holds the MBA degree from the University of Chinese Academy of Sciences.
Weikit Lau
Mr. Waikit Lau is a serial entrepreneur. With 17+ years of experience in Technology and Finance, across product, marketing, and sales functions, he has been on both VC and operations sides. He is an active investor in ICO and 20+ startups, and will be teaching an upcoming MIT class on cryptocurrency. Mr. Lau's past investments include BladeLogic, Endeca, WaveSmith, Netli, Berkeley Design Automation, among others. He is also running AIDL (Artificial Intelligence & Deep Learning), one of the largest and most active Artificial Intelligence and Deep Learning communities with 85,000+ members. Mr. Lau holds BS in Electrical Engineering, Finance & Computer Science from MIT and MBA from Harvard Business School.
Will Knight
Will Knight is MIT Technology Review’s Senior Editor for Artificial Intelligence. He covers the latest advances in AI and related fields, including machine learning, automated driving, and robotics. Will’s most recent cover story, The Dark Secret at the Heart of AI, examined the opaque nature of today's most cutting machine learning algorithms. He is currently researching a story about China's recent surge of activity in artificial intelligence. Will joined MIT Technology Review in 2008 from the UK science weekly New Scientist magazine. He is a frequent guest on TV and radio shows.
Dennis Zhang
Dennis is CEO and Co-Founder of VitaData, a decentralized health data kickstarter powered by blockchain. Dennis is also the architect of the token economics and held PhD in Economics from Boston University. He is an entrepreneur with 10 years of experience in data algorithm and analytics and also an expert in digital health, smart wear, blockchain and AI.
Tong Shen
Tong Shen is the Co-founder and CTO of Liaoyuan, a social networking platform for entrepreneurs, investors, and industry professionals to efficiently acquire valuable resources and connect with each other. Tong held Masters in Computer Science from Brandeis University. He is a serial entrepreneur with experience in social network, blockchain and app development.
Event Partner
BUMO is a new generation of commercial-grade basic public chain, and builds the Internet infrastructure for Ubiquitous Value Transfer through core technologies such as An Improved Two-layer Consensus Protocol (BU Firework), Two-layer Polymorphic Architecture for Multi-child Blockchain (BU Orbits), Inter-Chain for Routing Value across Blockchains (BU Canal), Developer-friendly Smart Contract on Blockchain (BU CodeMach), etc.
--
[About MIT CEO]
MIT CEO (MIT Chinese Entrepreneurs Organization) is a MIT-funded student group founded by a group of students and alumni from MIT, Harvard and other schools as well as young entrepreneurs and professionals around Boston area. Our mission is to help members to build world-class companies, to create a sustained collaboration mechanism between high-tech community and large Chinese corporations, as well as to help efficiently connect esteemed investors with high quality startups around Boston area. If you would like to hear about more MIT CEO events, please go to following page to subscribe to our mailing list mitceo-info@mit.edu: http://mailman.mit.edu/mailman/listinfo/mitceo-info. If you would like to contact MIT CEO, please e-mail to mitceo@mit.edu
< Flagship Pioneering > Case Study 案例讨论
With prof. Hong Luo of HBS
【Time/时间】
October 15, 6-8pm
6:00 - 6: 30 Reception with Light Dinner
6:30 - 8:00 Case Study
【Venue/地点】
MIT (Room number will be sent to your email address if invited)
【Language/语言】
English
【Co-host/协办】
PIP 破蛋计划
【Registration Link/注册链接】
A fee will be charged to participants to purchase the Case material from Harvard Business School. Due to limited capacity of the venue, your application will be reviewed by MIT CEO, and those who would benefit the most from this lecture will be invited to participate. If you are not invited, both ticket cost and fee will be fully refunded prior to the event.
本次活动将收费用于购买哈佛商学院案例。教材及活动地址将在报名入选后邮件发送。因名额有限，我们会对报名者职业背景进行筛选，挑选能够获益最多的学员参与。如您未被邀请参加，门票及手续费将在活动前全部退还。
The “Entrepreneuring” Vision
In 1987, Noubar Afeyan earned his Ph.D. in Biochemical Engineering from MIT and embarked upon the journey of entrepreneurship. Over the next decade, Dr. Afeyan contributed to the founding of six biotech companies, all of which went public or were acquired by the end of 1990s. As a serial entrepreneur, Noubar has the vision to transform the way startups are built: to systematically perpetuate entrepreneurship. Believing that Greater Boston has a strong ecosystem built of academic science, the hospitals, and the patient community, Dr. Afeyan founded Flagship in Cambridge.
Institutionalized Innovation
Since its inception in 2000, Flagship Pioneering has raised more than $2.32 billion in funds, launched more than 96 portfolio companies with an aggregated valuation of $20 billion, and managed funds proven to be top performers among all VCs of the same vintage. Compared to a number of medium and large biopharmaceutical companies, Flagship Pioneering exhibited four times productivity in patenting. Some of the successful companies include Moderna Therapeutics, Seres Therapeutics, Agios Pharmaceuticals, and Acceleron Pharma.
What is the business model of Flagship Pioneering that made “Institutionalized Entrepreneurship” possible?
What are the critical elements in Flagship’s strategy that create value?
As companies enter the growth phase, what are the challenges that Flagship face?
Hong Luo will present an overview of the important elements behind the success story of Flagship Pioneering, and her perspectives on how strategy contributed to the company.
About Professor Hong Luo
Hong Luo is the James Dinan and Elizabeth Miller Associate Professor at Harvard Business School, where she teaches strategy courses to MBA, Executive Education, and doctoral students. Her research focuses on the commercialization of innovative ideas and the strategy utilized by entrepreneurs. She lectures widely in the United States and internationally on topics including economics, entrepreneurship, and innovation. Prior to Harvard Business School, she taught at Sloan School of Management at MIT, and began her career at Boston Consulting Group. Dr. Luo received her Ph.D. in Economics from Stern School of Business, New York University, where she was a recipient of the Kauffman Dissertation Fellowship in Entrepreneurship Research. Prior to her doctorate, Dr. Luo received M.A. in Economics from Peking University and B.A. in Finance from Renmin University of China.
|
9月DoraHacks区块链&新科技Hack@波士顿
MIT、柏林、牛津、班加罗尔、首尔、东京，DoraHacks6个全球站点，6个全新篇章，挑战区块链、新科技、AI、游戏，碰撞出异域灵感的火花！
波士顿站
DoraHacks区块链&新科技Hack
9月22日-9月23日，你将与99位Hacker一起现场coding，在24小时内碰撞出区块链更多的创新应用，并从1万美金等值的数字货币中分走属于自己的荣耀。
你将与全世界最优秀的Hacker同台竞技，更有全天技术workshop以及数十个创业项目展示为你充电，准备好了吗？！
- 比赛时间：9月22日-9月23日
- 招募人数：100名（循环招募）
- 比赛地点：波士顿 BrainCo,120 Beacon St, Somerville, MA 02143
- 比赛形式：3~6人组队24小时Hack（自带团队或现场组队）
- 评价标准： 实用性、技术性、创意性；24H内增量。
- 带你见最顶尖的Hacker/新科技大佬；
- 聚拢全球最顶尖Hacker，奉上一场最高水平的、难忘的区块链&新科技Hackathon盛宴；
- 免费参与全天技术Workshop；
- 围观优秀创业项目展示。
波士顿 地区Evenbrite报名链接
https://www.eventbrite.com/e/dorahacks-blockchain-new-tech-hack-mit-tickets-49037515529
如有任何疑问，可扫描下方二维码加脑洞猫为微信好友，备注“@波士顿”
顾荣辉
哥伦比亚大学助理教授，CertiK创始人
2011年毕业于清华大学，获计算机科学学士学位；2016年毕业于耶鲁大学，获计算机科学博士学位。他的研究方向是软件系统的形式化验证，与耶鲁大学邵中教授一起设计并开发了首个经过完全验证的并发操作系统内核CertiKOS。联合创建了CertiK项目，致力于通过深度规范技术，构建可靠安全的区块链生态。
Gayatri
SportVEST 合伙人
Gayatri区块链风投的作家和其他区块链相关出版媒体的作者。曾担任波士顿联邦储备银行的经理，负责管理美联储最大的财政部项目。为财富500强客户和科技创业公司提供服务，并担任AI，医疗保健，风险投资，可再生的多个区块链和非区块链公司的董事会成员。
熊市下如何抄底寻找投资与发展机会？
北美首个区块链行业博览会袭来！
8 月 30 日（星期四） 9:00 AM - 6:00 PM
Crowne Plaza Times Square
1605 Broadway, New York, NY 10019
区块链无国界是一个由「燎原」联合星火区块链孵化器创立的国际性区块链品牌，区块链无国界的与会嘉宾、参会人员、项目团体无分种族、政治和宗教差异，致力于在世界各地汇聚和分享多方位的技术智慧，全面打通全球区块链体系，实现真正的无国界对话。
8 月 30 日「燎原」联合星火区块链孵化器正式发起区块链无国界数字博览会，此次活动将由专注于推广区块链行业的活动策划公司 Astrohash 承办。本次博览会将是首个以区块链为主题的博览会，超过 600+ 与会者，将有 50+ 个区块链项目展位，通过逛展讲演结合的社交模式，鼓励与会者面对面交流，促进会场投资和项目机构迸发更多合作可能性，抢先锁定更多投融资机会。
部分已确认嘉宾：
- David J. Namdar | Partner, Galaxy Digital
- S. Daniel Leon | Founding President & COO, Celsius Network
- Aries Wang | Cofounder, BiBox
- Gary Ross | Cofounder, Ross & Shulga PLLC
- Katina Stefanova | CEO & CIO, Marto Capital, former Senior Executive and Management Committee Advisor Bridge Water
- James Robert Collins | Former President of New York Mercantile Exchange
- Peter Borovykh | Blockchain Solution Architect, Blockchain Driven
- Victor T. Samuel | Founder & CEO, NV Global, former National Leader for Regulatory Compliance & AML
- Lingxiao Yang | Partner & COO, Trade Terminal
- Sam Doctor | Managing Director, Fundstrat Global Advisors
- Stephen Rutenberg | Shareholder, Polsinelli
- Brady Dale | Lead Journalist, CoinDesk
- Ray Zhang | CEO, Cointime
- Gary Chen | Cofounder & CEO, Deuro
- Jenny Vatrenko | Cofounder & COO, Oath Protocol
- Rum Yu | Partner, Collinstar
- Qi Su | Cofounder & CEO, Cingularity
- Liang Long | Cofounder & CEO, Carlife
- Leon Shi | Partner, Node Capital
- Yi Li | Cofounder & CEO, DaDao
前几天推送送票，很快就被抢空，很多用户反馈没有机会兑换。燎原作为主办方，再次为社区提供 50 张免费峰会入场券，先到先得，进入官方页面，输入折扣码，兑换入场券。
折扣码：liaoyuanbwb
我们 8 月 30 日，纽约不见不散！
Copyright © 2018 Liaoyuan. 242 Washington Street, 4th Fl., Boston MA 02108 USA. You are receiving this email because you are a member of the Liaoyuan.
You can update your preferences or unsubscribe from this list
• 今年5月25日，史上最严厉的数据保护法在欧洲通过，你想知道这
时间
2018年8月17日 晚6:30 至 8:00
报名链接
活动嘉宾
邹飞 博士
邹飞博士，协同资本的总经理兼HeliosData Inc 的董事长。在2012年创设协同资本之前，邹博士一直担任中国主
袁弘渊 博士
袁博士，中国科大本科，美国斯坦福大学物理博士，Helios Data Inc.核心创始成员，公司人工智能和数据团队负责人（http
Before joining Helios Data, Dr. Yuan was the chief scientist at Universal Labs(http://ulabs.technology) which focuses on providing the first decentralized personal cloud service with blockchain technology in the world.
Dr. Yuan was a machine learning scientist (project lead) at Adobe, direct report to VP of engineer. At Adobe, Dr. Yuan co-initialized the first machine learning training program with more than 1500 engineer participants globally in half a year, which won him Adobe’s special contribution recognition award. Dr. Yuan served at the program committee for the international conference on computational science in 2017, with 9 publications in top journals and 4 patents. His Ph.D. research has been reported by dozens of media including BBC and Elsevier.
Helios Data
Helios Data is a startup company based in Silicon Valley that leverage advanced AI and disruptive network technologies to enable legacy companies’ AI transformation by providing an AI empowered data infrastructure layer, which provides the following main features:
• Critical Data Discovery, Visibility and Relationship Mapping:
Helios’ disruptive, AI-empowered data discovery technology can help client discover and map out their critical data, both known and unknown, and build logical data groups with business intent - Data Defined Network (DDN), as a first step to start proper data utilization in any AI application
• Critical Data Security:
Different level of data securities can be applied to protect homogeneous groups of
critical data regardless their physical locations.
• Critical Data Compliance:
Helios’ innovative approach can identify and index data, and then follow up with further compliance actions to protect our customers from sky-rocketing fines.
• Critical Data Sharing and Monetization
| |||||||||
| |||||||||
|
|
研究所简介：
研究所简介：
江苏省产业技术研究院智能液晶技术研究所
北京大学分子工程苏南研究院简介
江苏省产业技术研究院先进金属材料及应用技术研究所
Hosted By:
MIT CEO 创业讲堂 第一期
「百济神州」哈佛商学院案例讲解
【时间】
2018年7月10日 晚6:00至8:00
6:00-6:30PM 招待会
6:30-8:00PM 案例讨论
【主办】
MIT CEO
破蛋计划
【协办】
南京大学波士顿校友会
本次活动收费将用于购买哈佛商学院案例。教材及活动地址将在报名入选后邮件发送。
1975年，旧金山。
在Kleiner & Perkins (现KPCB凯鹏华盈) 工作七年之后，二十八岁的Bob Swanson被迫决定自己出来创业。当时的他对基因重组 (Recombinant DNA) 技术的商业化有着浓厚兴趣，在无数套磁之后，他与时任UCSF微生物系教授Herb Boyer决定合伙创业。在得到老东家Kleiner & Perkins十万美元投资后，两人于一年后决定成立Genentech。
2010年，北京。
是什么促使归国七年的王晓东与连续创业的欧雷强 (John Oyler) 走到了一起？百济神州具体的商业计划又是什么？CFDA政策变化在百济成立前后又有着怎样的影响？
1978年，面临资金压力，Genentech急需用制造人类胰岛素来证明自己实力。丹麦Novo Industri与德国Hoechst AG接连拒绝了合作请求。Genentech同时也与UCSF与Harvard两支学术团队就制造胰岛素进行着激烈竞争。从一个纸面上的virtual company开始扩张招人，Genentech凭借政策监管上的优势，领先于其他学术团队完成合成，最终与礼来签下一纸二十年数百万的研发合同，从此步入正轨。彼时彼刻，美国国会正拟对基因重组相关技术加重法规监管。Genentech在生长抑素(somatostatin) 生产制造的成功，在这场政策交锋中起到了至关重要的作用。
2013年初，百济神州在创立不到三年后遇到巨大的困境，一方面资金严重短缺，另一方面提供早期投资的Merck对百济在研产品管线没有足够兴趣进而达成交易。在当时生物医药的融资寒冬时，投资人估值也并不理想。
是什么驱使百济神州的两位创始人在创业时决定以Genentech作为目标？跌宕起伏的故事之外，百济神州的历程对于当下如火如荼的生物制药产业来说，又有怎样的启发。
What was relevant then?
Why is it still relevant now?
张志民博士曾代表Merck在百济神州的董事会里负责与百济的沟通和联盟管理，目睹了企业的成长与商务拓展在融资与发展中至关重要的影响。去年，他与哈佛商学院Willy Shih教授共同撰写了哈佛商学院的《百济神州》案例与教案。此次我们有幸邀请张志民博士来讲解剖析百济神州从融资到BD，创新团队和商业模式的转变，到走向成熟的过程。
张志民 博士，MBA
张志民博士为礼来亚洲基金风险合伙人。曾任强生创新商务合作全球副总裁，负责强生医药、医疗器械和诊断、及消费品三个事业部在亚太地区的创新商务拓展和合作及策略，并负责创新基金的关系和合作。加入强生前，张博士是默沙东(Merck)大中华区早期投资董事总经理，默沙东中国研发中心高层管理团队成员。负责美国默克在大中华区商务拓展、技术转让、并购及对外研发合作、联盟和合作伙伴的管理以及风险投资。张博士曾任百济神州董事和千骥资本 (Cenova) 指导委员会。
张博士曾任美国协能基因控股集团资深副总裁。协能基因乃是美国生物技术先驱和奠基人之一的美国科学院院士William J. Rutter博士创建并领导的私募基金、投资控股公司和生物技术孵化加速器。张博士负责协能基因及麾下公司的事业拓展业务以及在中国的业务。张博士曾任职于麦肯锡咨询公司；在世界领先、担任北京奥运会组委会法律顾问的美国美富律师事务所 (Morrison & Foerster) Palo Alto分所任注册专利代理人；在当时全美第二大生物技术公司Chiron公司 (现为诺华制药)担任项目经理。
张志民博士在南京大学获生物化学学士学位，在德克萨斯州大学达拉斯西南医学中心获生物医学博士学位，其间从师三位诺贝尔奖获得者。在麻省理工学院斯隆管理学院攻读MBA期间，张博士当选为全校研究生总会的财务长，入围第十二届MIT $50K Entrepreneurship Competition (now MIT $100K)决赛。
---
【关于MIT CEO】
麻省理工学院华人创业者协会 (MITChinese Entrepreneurs Organization, MIT CEO) 是由MIT和Harvard等校的学生和校友以及波士顿周边的年轻创业者、职场人士成立的非营利组织，致力于帮助麻省理工学院及周边的华人创业者建立世界级的企业，创造中国高科技企业与麻省理工学院及周边高新科技的长期对接机制，构建优质投资机构与波士顿地区华人创业者的高效对接交流的平台。有意愿加入我们并参与MIT CEO日常运营请发送邮件到mitceo@mit.edu咨询。
【关于破蛋计划】
破蛋计划 (Podan Innovation Plan) 是注册于美国麻省的501(c)3非盈利机构，目前在波士顿，旧金山，中国大陆和新加坡均有设立分会。破蛋计划以波士顿为根基，集结了中美生命科学及相关领域医学、科学、技术、产业以及商业方面的顶级人才。破蛋计划旨在打造中美生命科学产业高端智库以推动生命科技产业化，打破跨领域人才合作、技术产业化以及资金对接壁垒，促进早期生命科学创投项目的孵化与诞生。
OCEAN
创响全球 太仓全球创业大赛美国分赛区 起航! :
基因工程进展：对全球中国家庭的影响、机遇和风险
2018年5月31日
晚6:00至9:00
哈佛大学医学院
【主办】
哈佛大学医学院 遗传学系
Personal Genetics Education Project（pgEd）
MIT 华人创业者协会 (MIT CEO)
我们对基因组进行测序的能力，结合大数据分析以及实现DNA编辑的相关技术，对人类健康和长寿将产生巨大的影响，同时也提供了巨大的投资空间和就业机会。
此次研讨会我们专门为波士顿地区的中国学生、专业人士和他们的家庭设计，介绍最新的基因工程技术及治疗应用，定制新生婴儿的可能，以及基因工程在教育和执法方面的应用。我们将探讨此间不可避免的伦理挑战，你也会听到哈佛医学院教授介绍技术的革新，哈佛学者介绍他们的职业道路，企业家分析他们的成功创业路径，以及家族财富顾问讨论投资机会。
我们诚挚邀请您参加这次的探讨。此次讨论会将用英文交流，配以中文翻译。
注册请点击：https://goo.gl/forms/EtQcd9SJBedJb1Yz2
更多信息请发送电子邮件至 yaov@mit.edu
请注意，此次免费活动需要提前报名。您成功注册后我们会发送邮件确认并通知活动地点，您的名字将在大楼安保入口处报备，以便您获准进入。
议程
时间
活动
6：00-6：40PM
注册与招待会
6：40-6：45PM
欢迎致辞
Florence Tsai, Executive Director of Family Enterprise Global Innovation Institute
6：45-7：15PM
遗传学研究及其应用的突破
Prof. Ting Wu, Professor at the Harvard Medical School Genetics Department
7：15-7：30PM
pgEd介绍
Marnie Gelbart, Director of Programs at pgEd
7：30-8：10PM
遗传信息及其对财富家庭的影响
Florence Tsai and Ronnie Stangler, Professor of Behavioral Sciences at Univ. of Washington
8：10-8：45PM
在生物科技领域的投资和就业机会和遗传学经济
Harvard Medical School research lab, Morgan Stanley Wealth Advisors, Area biotech entrepreneur
8：45-9：00PM
反思与总结
Prof. Ting Wu, Florence Tsai, and Ronnie Stangler
主办委员会
Ting Wu, Ph.D. - Prof. of Genetics, Harvard Medical School; Director and Co-Founder of pgEd
Florence Tsai, M.B.A., M.P.A. - Director, Family Enterprise Global Innovation Institute
Ronnie S. Stangler, M.D. ? Prof. of Behavioral Sciences, University of Washington; Advisor, pgEd; Co-Founder, Genome Advisory
活动合作伙伴 Family Enterprise Global Innovation Institute
活动赞助商 Morgan Stanley Wealth Management
|
MIT CEO 创业讲堂 第一期
「百济神州」哈佛商学院案例讲解
【时间】
2018年7月10日 晚6:00至8:00
6:00-6:30PM 招待会
6:30-8:00PM 案例讨论
【主办】
MIT CEO
破蛋计划
【协办】
南京大学波士顿校友会
本次活动收费将用于购买哈佛商学院案例。教材及活动地址将在报名入选后邮件发送。
1975年，旧金山。
在Kleiner & Perkins (现KPCB凯鹏华盈) 工作七年之后，二十八岁的Bob Swanson被迫决定自己出来创业。当时的他对基因重组 (Recombinant DNA) 技术的商业化有着浓厚兴趣，在无数套磁之后，他与时任UCSF微生物系教授Herb Boyer决定合伙创业。在得到老东家Kleiner & Perkins十万美元投资后，两人于一年后决定成立Genentech。
2010年，北京。
是什么促使归国七年的王晓东与连续创业的欧雷强 (John Oyler) 走到了一起？百济神州具体的商业计划又是什么？CFDA政策变化在百济成立前后又有着怎样的影响？
1978年，面临资金压力，Genentech急需用制造人类胰岛素来证明自己实力。丹麦Novo Industri与德国Hoechst AG接连拒绝了合作请求。Genentech同时也与UCSF与Harvard两支学术团队就制造胰岛素进行着激烈竞争。从一个纸面上的virtual company开始扩张招人，Genentech凭借政策监管上的优势，领先于其他学术团队完成合成，最终与礼来签下一纸二十年数百万的研发合同，从此步入正轨。彼时彼刻，美国国会正拟对基因重组相关技术加重法规监管。Genentech在生长抑素(somatostatin) 生产制造的成功，在这场政策交锋中起到了至关重要的作用。
2013年初，百济神州在创立不到三年后遇到巨大的困境，一方面资金严重短缺，另一方面提供早期投资的Merck对百济在研产品管线没有足够兴趣进而达成交易。在当时生物医药的融资寒冬时，投资人估值也并不理想。
是什么驱使百济神州的两位创始人在创业时决定以Genentech作为目标？跌宕起伏的故事之外，百济神州的历程对于当下如火如荼的生物制药产业来说，又有怎样的启发。
What was relevant then?
Why is it still relevant now?
张志民博士曾代表Merck在百济神州的董事会里负责与百济的沟通和联盟管理，目睹了企业的成长与商务拓展在融资与发展中至关重要的影响。去年，他与哈佛商学院Willy Shih教授共同撰写了哈佛商学院的《百济神州》案例与教案。此次我们有幸邀请张志民博士来讲解剖析百济神州从融资到BD，创新团队和商业模式的转变，到走向成熟的过程。
张志民 博士，MBA
张志民博士为礼来亚洲基金风险合伙人。曾任强生创新商务合作全球副总裁，负责强生医药、医疗器械和诊断、及消费品三个事业部在亚太地区的创新商务拓展和合作及策略，并负责创新基金的关系和合作。加入强生前，张博士是默沙东(Merck)大中华区早期投资董事总经理，默沙东中国研发中心高层管理团队成员。负责美国默克在大中华区商务拓展、技术转让、并购及对外研发合作、联盟和合作伙伴的管理以及风险投资。张博士曾任百济神州董事和千骥资本 (Cenova) 指导委员会。
张博士曾任美国协能基因控股集团资深副总裁。协能基因乃是美国生物技术先驱和奠基人之一的美国科学院院士William J. Rutter博士创建并领导的私募基金、投资控股公司和生物技术孵化加速器。张博士负责协能基因及麾下公司的事业拓展业务以及在中国的业务。张博士曾任职于麦肯锡咨询公司；在世界领先、担任北京奥运会组委会法律顾问的美国美富律师事务所 (Morrison & Foerster) Palo Alto分所任注册专利代理人；在当时全美第二大生物技术公司Chiron公司 (现为诺华制药)担任项目经理。
张志民博士在南京大学获生物化学学士学位，在德克萨斯州大学达拉斯西南医学中心获生物医学博士学位，其间从师三位诺贝尔奖获得者。在麻省理工学院斯隆管理学院攻读MBA期间，张博士当选为全校研究生总会的财务长，入围第十二届MIT $50K Entrepreneurship Competition (now MIT $100K)决赛。
---
【关于MIT CEO】
麻省理工学院华人创业者协会 (MITChinese Entrepreneurs Organization, MIT CEO) 是由MIT和Harvard等校的学生和校友以及波士顿周边的年轻创业者、职场人士成立的非营利组织，致力于帮助麻省理工学院及周边的华人创业者建立世界级的企业，创造中国高科技企业与麻省理工学院及周边高新科技的长期对接机制，构建优质投资机构与波士顿地区华人创业者的高效对接交流的平台。有意愿加入我们并参与MIT CEO日常运营请发送邮件到mitceo@mit.edu咨询。
【关于破蛋计划】
破蛋计划 (Podan Innovation Plan) 是注册于美国麻省的501(c)3非盈利机构，目前在波士顿，旧金山，中国大陆和新加坡均有设立分会。破蛋计划以波士顿为根基，集结了中美生命科学及相关领域医学、科学、技术、产业以及商业方面的顶级人才。破蛋计划旨在打造中美生命科学产业高端智库以推动生命科技产业化，打破跨领域人才合作、技术产业化以及资金对接壁垒，促进早期生命科学创投项目的孵化与诞生。
创响全球 太仓全球创业大赛美国分赛区 起航! :
基因工程进展：对全球中国家庭的影响、机遇和风险
2018年5月31日
晚6:00至9:00
哈佛大学医学院
【主办】
哈佛大学医学院 遗传学系
Personal Genetics Education Project（pgEd）
MIT 华人创业者协会 (MIT CEO)
我们对基因组进行测序的能力，结合大数据分析以及实现DNA编辑的相关技术，对人类健康和长寿将产生巨大的影响，同时也提供了巨大的投资空间和就业机会。
此次研讨会我们专门为波士顿地区的中国学生、专业人士和他们的家庭设计，介绍最新的基因工程技术及治疗应用，定制新生婴儿的可能，以及基因工程在教育和执法方面的应用。我们将探讨此间不可避免的伦理挑战，你也会听到哈佛医学院教授介绍技术的革新，哈佛学者介绍他们的职业道路，企业家分析他们的成功创业路径，以及家族财富顾问讨论投资机会。
我们诚挚邀请您参加这次的探讨。此次讨论会将用英文交流，配以中文翻译。
注册请点击：https://goo.gl/forms/EtQcd9SJBedJb1Yz2
更多信息请发送电子邮件至 yaov@mit.edu
请注意，此次免费活动需要提前报名。您成功注册后我们会发送邮件确认并通知活动地点，您的名字将在大楼安保入口处报备，以便您获准进入。
议程
时间
|
活动
|
6：00-6：40PM
|
注册与招待会
|
6：40-6：45PM
|
欢迎致辞
Florence Tsai, Executive Director of Family Enterprise Global Innovation Institute
|
6：45-7：15PM
|
遗传学研究及其应用的突破
Prof. Ting Wu, Professor at the Harvard Medical School Genetics Department
|
7：15-7：30PM
|
pgEd介绍
Marnie Gelbart, Director of Programs at pgEd
|
7：30-8：10PM
|
遗传信息及其对财富家庭的影响
Florence Tsai and Ronnie Stangler, Professor of Behavioral Sciences at Univ. of Washington
|
8：10-8：45PM
|
在生物科技领域的投资和就业机会和遗传学经济
Harvard Medical School research lab, Morgan Stanley Wealth Advisors, Area biotech entrepreneur
|
8：45-9：00PM
|
反思与总结
Prof. Ting Wu, Florence Tsai, and Ronnie Stangler
|
主办委员会
Ting Wu, Ph.D. - Prof. of Genetics, Harvard Medical School; Director and Co-Founder of pgEd
Florence Tsai, M.B.A., M.P.A. - Director, Family Enterprise Global Innovation Institute
Ronnie S. Stangler, M.D. ? Prof. of Behavioral Sciences, University of Washington; Advisor, pgEd; Co-Founder, Genome Advisory
活动合作伙伴 Family Enterprise Global Innovation Institute
活动赞助商 Morgan Stanley Wealth Management
|
【MIT-CHIEF & Harvard】“浪潮之巅区块链大会”——区块链的商业、监管与科技
活动详情
2018年4月7日 9:00AM - 5:00PM EST
观众报名链接：
部分嘉宾名单
Amber Baldet
Andy Bromberg
Anil Advani
Bennett Collen
Caitlin Long
Joe Raczynski
观众报名链接：
特别鸣谢
中关村波士顿创新中心旨在搭建中美创新交流的桥梁，加速推动中美创新合作。创新中心设有孵化器，跨境办公室，政府招商引智窗口，海外研发中心等多种共享空间，既吸引波士顿的创新企业入驻孵化、给当地创造就业和经济机会，又将作为中关村及中国企业对外合作的创新窗口。
Circle是一家P2P支付技术公司，于2013年10月创立。Circle的移动支付平台Circle Pay允许用户持有，发送和接收传统法定货币。
MIT-CHIEF是附属于麻省理工学院的学生组织，自创立伊始，已成为美国东部华人第一大创业社区。通过创业年会、商业计划大赛、中国行、明珠计划等一系列品牌活动，为中美两地创业生态圈建立了一条“丝绸之路”。同时，MIT-CHIEF创业社区所提供的创业沙龙、前沿科技论坛、培训项目和导师项目等等陪伴着一代又一代的逐梦人一路同行与成长。
点击“阅读原文”直达购票连接
【MIT-CHIEF & Harvard】“浪潮之巅区块链大会”——区块链的商业、监管与科技
Anil Advani
Bennett Collen
Caitlin Long
本期HMS-CSSA创业沙龙请到了启明创投（Qiming Venture Partners）
的管理合伙人梁颖宇（Nisa Leung）
来为大家分享生物科技投资的经验和故事
机会难得，不容错过！
语言：英文
嘉宾简介：
Nisa Leung (梁颖宇) is a Managing Partner of Qiming Venture Partners and leading its health care investments. Qiming Venture Partners is a leading investment firm in China which currently manages over USD 3 billion in assets and investment in over 240 companies.
Nisa was named Venture Capital Professional of the Year by Asian Venture Capital Journal in 2017 and Top 3 Best Female Venture Capitalist by Forbes in 2018. She currently sits on the board of Gan & Lee Pharmaceutical, Zai Lab (NASDAQ: ZLAB), Nurotron, Venus MedTech, Goodwill Information Technology, dMed, LIH Rehabilitation, CanSino Biotechnology and Berry Genomics (SZSE:000710). Her other investments include Acea Biosciences, Aeonmed Medical, CITIC Pharmaceuticals (acquired by Shanghai Pharmaceutical HKSE: 02607), Crown Bioscience (GTSM: 6554), Origene Technologies (acquired by VCAN Bio SHSE: 600645), Richen, Wuxi Leiming, Chain Medical Labs, Suzhou Qiagen, New Horizon Bio and Jacobio.
Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, a founding member and Vice Chair of PhIRDA Investment Committee, member of Committee on Hong Kong Innovation and Technology (I&T) Development and Re-Industrialization, advisor of Our Hong Kong Foundation, founder of Venture Investors Alliance of Hong Kong, council member of HKUST Business School and serves on the Board of Governors of the Hotchkiss School.
（叶琼）
注册方式:
请通过扫描下方二维码注册或点击
第二屆深圳國際創新創業大賽波士頓分區賽
You are invited to join the above event on 3/21/2018.
Please register via this link: https://www.eventbrite.com/e/boston-division-innovation-entrepreneurship-international-competition-tickets-42733996534?aff=es2
If you'd like, you may also register through MIT CHIEF's EventBrite page: https://www.eventbrite.com/e/the-second-china-innovation-entrepreneurship-international-competition-tickets-43379724925?aff=es2
第二届国际赛波士顿区分赛 火热报名中
Highlight
第二届中国深圳创新创业大赛第二届国际赛波士顿区分赛 火热报名中
·2018年3月21日于哈佛医学院Martin Conference Center隆重举办
·总奖金超过一千万人民币
·来自中国、波士顿和全美地区的投资者
· 顶尖学者如Robert Langer的演讲
· 顶尖中美投资者、策略伙伴、领域巨擘，三种愿望一次满足
报名截止日期为2018年2月28日
报名地址：http://apply.itcsz.cn/elogin-boston2018-en
【承办方介绍】
EGI Capital是一个在波士顿剑桥市的风投和私募基金，主要投资种子期和后期新创公司，领域涵盖资料信息科技和健康照护的新创公司。EGI Capital的Co-Founder Dr. Charles Hsu拥有麻省理工学院计算机工程博士学位、管理学硕士学位及哈佛大学法律学位，并有累积超过二十年业界及多次成功创业的经验，更曾在麻省理工学院任教、”MIT科技评论”中文版撰写。
【赛事介绍】
中国（深圳）创新创业大赛第二届“国际赛”（下称“第二届双创赛”），由中华人民共和国科学技术部、中华人民共和国国家外国专家局指导，深圳市人民政府主办，其波士顿分赛区赛事由EGI Capital承办。大赛旨在积极响应“大众创业、万众创新”的号召，深入实施创新驱动发展，集聚海外高端人才优质项目，整合创新创业资源，助力深圳建设国际科技产业创新中心。
本次大赛面向所有的海外高层次人才和项目开放，参赛者不限国籍。大赛设立了丰厚的奖金，总奖金达1091万元人民币，单个选手最高可获得大赛奖金140万元人民币（不包含政府资助及创投资金），参与本次大赛的创投机构达34家，组合形成总额209亿元人民币的创投资金池，对大赛优秀项目进行组合投资。所有参赛项目均可通过大赛投资对接服务平台获得社会资本的投资机会，并受邀来深参加中国国际人才交流大会。
这场比赛深圳市政府不只提供高额奖金，更针对新创公司的需求，提供策略伙伴、对的人脉连结和中国行。在全世界拥有九个不同区分赛，五个领域，双创赛建构了一个全球性的平台，连结最创新的新创、专业人士和投资者。此外，本次大赛还提供人才激励、产业奖励、科技金融、项目孵化等政策支持。
EGI与深圳合伙人（CRI源创力离岸创新中心）将在3月21日举办第二届双创赛波士顿分赛，总共包含五大领域：
1. 互联网和移动互联网
(信息科技)
2. 电子科技
3. 生物与生命科技
4. 先进制造和材料
5. 能源(含节能环保)
经过第一轮初审之后，二十支创业团队将脱颖而出，参加3月21日举办的现场答辩，评选出高达六名的一二三等奖。
一等奖1名，奖金10万人民币
二等奖2名，奖金各5万人民币
三等奖3名，奖金各3万人民币
在一二三等奖之外，也将会在每个领域的选出前两名（共计10支团队），获奖团队可以获得免费的机票和住宿参加2018年4月10-12日在中国的最终决赛，角逐100万人民币大奖，并将有大量投资和合作机会。
5大领域的行业专家与新创团队
学术菁英共同探讨未来科技发展方向
20支高新科技创业项目激烈竞争35万人民币
顶尖中美投资者、策略伙伴、各领域巨擘，三种愿望一次满足
我们竭诚地邀请各路英雄豪杰，不管是新创团队或听众，和我们一起共襄盛举。 此场盛会适合拥有改变世界野心或了解趋势变化的每一个小伙伴！
点击 阅读原文
跳转至活动网址
Highlight
第二届中国深圳创新创业大赛第二届国际赛波士顿区分赛 火热报名中
·2018年3月21日于哈佛医学院Martin Conference Center隆重举办
·总奖金超过一千万人民币
·来自中国、波士顿和全美地区的投资者
· 顶尖学者如Robert Langer的演讲
· 顶尖中美投资者、策略伙伴、领域巨擘，三种愿望一次满足
报名截止日期为2018年2月28日
报名地址：http://apply.itcsz.cn/elogin-boston2018-en
报名地址：http://apply.itcsz.cn/elogin-boston2018-en
【承办方介绍】
EGI Capital是一个在波士顿剑桥市的风投和私募基金，主要投资种子期和后期新创公司，领域涵盖资料信息科技和健康照护的新创公司。EGI Capital的Co-Founder Dr. Charles Hsu拥有麻省理工学院计算机工程博士学位、管理学硕士学位及哈佛大学法律学位，并有累积超过二十年业界及多次成功创业的经验，更曾在麻省理工学院任教、”MIT科技评论”中文版撰写。
【赛事介绍】
中国（深圳）创新创业大赛第二届“国际赛”（下称“第二届双创赛”），由中华人民共和国科学技术部、中华人民共和国国家外国专家局指导，深圳市人民政府主办，其波士顿分赛区赛事由EGI Capital承办。大赛旨在积极响应“大众创业、万众创新”的号召，深入实施创新驱动发展，集聚海外高端人才优质项目，整合创新创业资源，助力深圳建设国际科技产业创新中心。
本次大赛面向所有的海外高层次人才和项目开放，参赛者不限国籍。大赛设立了丰厚的奖金，总奖金达1091万元人民币，单个选手最高可获得大赛奖金140万元人民币（不包含政府资助及创投资金），参与本次大赛的创投机构达34家，组合形成总额209亿元人民币的创投资金池，对大赛优秀项目进行组合投资。所有参赛项目均可通过大赛投资对接服务平台获得社会资本的投资机会，并受邀来深参加中国国际人才交流大会。
这场比赛深圳市政府不只提供高额奖金，更针对新创公司的需求，提供策略伙伴、对的人脉连结和中国行。在全世界拥有九个不同区分赛，五个领域，双创赛建构了一个全球性的平台，连结最创新的新创、专业人士和投资者。此外，本次大赛还提供人才激励、产业奖励、科技金融、项目孵化等政策支持。
EGI与深圳合伙人（CRI源创力离岸创新中心）将在3月21日举办第二届双创赛波士顿分赛，总共包含五大领域：
1. 互联网和移动互联网
(信息科技)
2. 电子科技
3. 生物与生命科技
4. 先进制造和材料
2. 电子科技
3. 生物与生命科技
4. 先进制造和材料
5. 能源(含节能环保)
经过第一轮初审之后，二十支创业团队将脱颖而出，参加3月21日举办的现场答辩，评选出高达六名的一二三等奖。
一等奖1名，奖金10万人民币
二等奖2名，奖金各5万人民币
三等奖3名，奖金各3万人民币
在一二三等奖之外，也将会在每个领域的选出前两名（共计10支团队），获奖团队可以获得免费的机票和住宿参加2018年4月10-12日在中国的最终决赛，角逐100万人民币大奖，并将有大量投资和合作机会。
5大领域的行业专家与新创团队
学术菁英共同探讨未来科技发展方向
20支高新科技创业项目激烈竞争35万人民币
顶尖中美投资者、策略伙伴、各领域巨擘，三种愿望一次满足
我们竭诚地邀请各路英雄豪杰，不管是新创团队或听众，和我们一起共襄盛举。 此场盛会适合拥有改变世界野心或了解趋势变化的每一个小伙伴！
跳转至活动网址
中国深圳创新创业大赛第二届国际赛波士顿分站赛正式启动！
|
|
No comments:
Post a Comment